Bibliography
- Nath D , HhmelsM-T, AnsonL: Nature insight: obesity and diabetes.Nature444, 839–888 (2006).
- Griffin JL : Metabolic profiles to define the genome: can we hear the phenotypes?Philos. Trans. R. Soc. Lond. B Biol. Sci. 29, 359(1446), 857–871 (2004).
- Goodacre R : Metabolomics of a superorganism.J. Nutr.137(1 Suppl.), S259–S266 (2007).
- German JB , GilliesLA, SmilowitzJT, ZivkovicAM, WatkinsSM: Lipidomics and lipid profiling in metabolomics.Curr. Opin. Lipidol.18(1), 66–71 (2007).
- Jellum E , StorsethP, AlexanderJ, HellandP, StokkeO, TeigE: Application of glass capillary-column gas chromatography-mass spectrometry to the studies of human diseases.J. Chromatogr.3(126), 487–493 (1976).
- Rhodes G , MillerM, McConnellML, NovotnyM: Metabolic abnormalities associated with diabetes mellitus, as investigated by gas chromatography and pattern-recognition analysis of profiles of volatile metabolites.Clin. Chem.27(4), 580–585 (1981).
- Beckwith-Hall BM , NicholsonJK, NichollsAWet al.: Nuclear magnetic resonance spectroscopic and principal components anlysis investigations into biochemical effects of three model hepatotoxins.Chem. Res. Toxicol.11, 260–272 (1998).
- El-Deredy W , AshmoreSM, BranstonNM, DarlingJL, WilliamsSR, ThomasDG: Pretreatment prediction of the chemotherapeutic response of human glioma cell cultures using nuclear magnetic resonance spectroscopy and artificial neural networks.Cancer Res.57, 4196–4199 (1997).
- Kussmann M , RaymondF, AffolterM: OMICS-driven biomarker discovery in nutrition and health.J. Biotechnol.124(4), 758–787 (2006).
- Griffin JL , NichollsAW: Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders.Pharmacogenomics7(7), 1095–1107 (2006).
- Summers LK : Adipose tissue metabolism, diabetes and vascular disease-lessons from in vivo studies.Diab. Vasc. Dis. Res.3(1), 12–21 (2006).
- Corthesy-Theulaz I , den DunnenJT, FerrePet al.: Nutrigenomics: the impact of biomics technology on nutrition research.Ann. Nutr. Metab.49(6), 355–365 (2005).
- Hochberg Z : Metabolomics of the obese.Int. J. Obes. (Lond.)30(Suppl. 2), S4 (2006).
- Lacey ME , TanZJ, WebbAG, SweedleJV: Union of capillary high-performance liquid chromatography and microcoil nuclear magnetic resonance spectroscopy applied to the separation and identification of terpenoids.J. Chromatogr. A922, 139–149 (2001).
- Keun HC , BeckonertO, Griffin JL et al.: Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal. Chem.74(17), 4588–4593 (2002).
- Han X , GrossRW: Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes.Expert Rev. Proteomics2(2), 253–264 (2005).
- Oikawa A , NakamuraY, OguraTet al.: Clarification of pathway-specific inhibition by Fourier transform ion cyclotron resonance/mass spectrometry-based metabolic phenotyping studies. Plant Physiol.142(2), 398–413 (2006).
- Hollywood K , BrisonDR, GoodacreR: Metabolomics: current technologies and future trends.Proteomics6(17), 4716–4723 (2006).
- Atherton HJ , BaileyNJ, ZhangWet al.: A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-α null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome.Physiol. Genomics27(2), 178–186 (2006).
- Williams RE , LenzEM, RantalainenM, WilsonID: The comparative metabonomics of age-related changes in the urinary composition of male Wistar-derived and Zucker (fa/fa) obese rats.Mol. Biosyst.2(3–4), 193–202 (2006).
- Pietiläinen KH , Sysi-AhoM, RissanenAet al.: Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects – a monozygotic twin study. PLoS ONE2, E218 (2007).
- Kolak M , WesterbackaJ, VelagapudiVRet al.: Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes56(8), 1960–1968 (2007).
- Medina-Gomez G , GraySL, YetukuriLet al.: PPAR γ 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet.3(4), E64 (2007).
- Serkova NJ , JackmanM, BrownJLet al.: Metabolic profiling of livers and blood from obese Zucker rats.J. Hepatol.44, 956–962 (2006).
- Watkins SM , ReifsnyderPR, PanHJ, GermanJB, LeiterEH: Lipid metabolome-wide effects of the PPARγ agonist rosiglitazone.J. Lipid Res.43(11), 1809–1817 (2002).
- Yetukuri L , KatajamaaM, Medina-GomezG, Seppanen-LaaksoT, Vidal-PuigA, OresicM: Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.BMC Syst. Biol.1, 12 (2007).
- Bijlsma S , BobeldijkI, VerheijERet al.: Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal. Chem.78(2), 567–574 (2006).